Abstract 089
Long-term fistula healing and response through 24 months of adalimumab therapy
Months since CHARM baseline
Fistula healing* n (%)
⩾50% Fistula response* n (%)
6
35 (50)
45 (64)
12
35 (50)
41 (59)
18
39 (56)
50 (71)
24
42 (60)
50 (71)
*Includes all ADA patients, EOW+EW (n = 70), with fistulas at CHARM baseline.